According to the latest research by Future Market Insights, Needle-Free Vaccine Injectors Market is set to experience xxx% growth during the year 2021-2031. The growth of the needle free vaccine injectors market is attributed due to the increase in prevalence of various number of chronic diseases, rising chances of communicable disease due to needle stick injuries, growing demand for vaccination and biosimilars and furthermore, the growing demand for the self-injection devices.
What is driving Demand for Veterinary Home Diagnostics?
Growth in the number of communicable disease due to needle stick injuries is one of the major factors driving the growth of the market. Needle free vaccine injectors are basically used in the administration of drugs, vaccines and liquid formulations.
The demand for this system is significantly rising over the forecast period as they enhance immune response to vaccination, reduction in healthcare cost and also eliminates risks of needles. However, lack of practice and skilled professionals along with the constricted usage of needle free vaccine injectors for intravenous administration hampers the market growth.
Moreover, growing advantages of drug delivery technology and also the rise in demand for self-injection devices are the other few key factors driving the needle free vaccine injectors market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Reduction in the Risk of Skin Puncture or Swelling Issues is Likely to Augment Needle Free Vaccine Injectors Market
Needle free vaccine injectors market provides the user with various benefits such as reduction of risks of skin puncture or swelling issues and also bleeding in few cases.
Furthermore, according to the study various associations such as World health organization and the Centre for Disease control (CDC) and different other organizations such as the gates foundation serves the requirement of needle free drug delivery options that will form huge number of growth opportunities in the near future.
Thus, needle free vaccine injectors are the equipment’s that are put into use without abrading the skin with the help of traditional needle to deliver various medicines, vaccines and fluid medications.
U.S. and Canada Needle-Free Vaccine Injectors Market Outlook
U.S. and Canada are expected to have the highest share and therefore will dominate the Needle-Free Vaccine Injectors Market. The speedy growth of the market is due to increase in prevalence of chronic conditions, growth in demand for biologics, various trending technological advancements, acquisitions and mergers taking place between key players to improve the production and quality, reimbursement policies, growth in healthcare spending’s and the approval of new needle free vaccine injector system are the major factors driving the regional growth of U.S. and Canada over the forecast period.
Find your sweet spots for generating winning opportunities in this market.
Europe Demand Outlook for Needle-Free Vaccine Injectors Market
The European market for needle-free vaccine injectors is estimated to grow at a considerable rate during the forecast period. This surge in growth is due to the increasing prevalence of chronic diseases, growing demand for biologics, merger and acquisitions by major key players, significant rise in healthcare expenditure along with regulatory approvals of new needle free vaccine injectors are the key points driving the European regional outlook.
According to Hindustan times, BYL Nair hospital in Mumbai central has secured the first place in civic run hospital to start with the phase 3 trial of ZyCoV-D vaccine on children’s amid covid-19 pandemic.
Who are the Key Manufacturers and Suppliers of Needle-Free Vaccine Injectors Market?
Some of the key players operating in the Needle-Free Vaccine Injectors Market are
Antares Pharma, Inc. (U.S.)
INJEX Pharma AG (Germany)
Endo International plc (U.S.)
PharmaJet (U.S)
European Pharma Group (Netherland)
Bioject Medical Technologies Inc. (U.S)
Medical International Technology, Inc. (U.S)
Valeritas, Inc. (U.S.)
National Medical Products Inc. (U.S.)
PenJet Corporation (U.S)
Crossject SA (France)
Manufacturers in the market focus on carrying out certain strategic activities such as acquisitions and merger, expansion, product launch, etc. For instance, in May 2019, Novartis innovated EpiPen at a base price of about $ 250.0, which is considers to be the cheapest as compared to the other products in the market.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
